In vivo, co-injection of CD70-expressing fibroblasts with cSCC cells accelerates tumor growth, whereas CD70 knockdown impairs tumor progression and reduces PCNA, IL6, and MCP3 expression, confirming its functional relevance in the tumor microenvironment. The gene discussed is CCL7; the disease is neoplasm.